Review of the guideline of the American College of Physicians on the treatment of osteoporosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Review of the guideline of the American College of Physicians on the treatment of osteoporosis
Authors
Keywords
Bone mineral density, Fracture risk, FRAX, Intervention thresholds, Treatment guidelines
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 29, Issue 7, Pages 1505-1510
Publisher
Springer Nature
Online
2018-06-05
DOI
10.1007/s00198-018-4504-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial
- (2018) Lee Shepstone et al. LANCET
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2018) David L Kendler et al. LANCET
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
- (2017) Athanasios D Anastasilakis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study
- (2017) Eugene V McCloskey et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting
- (2017) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Editorial: Response to the American College of Physicians Osteoporosis Guideline, 2017 Update
- (2017) Liron Caplan et al. Arthritis & Rheumatology
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- UK clinical guideline for the prevention and treatment of osteoporosis
- (2017) J. Compston et al. Archives of Osteoporosis
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS — 2016--EXECUTIVE SUMMARY
- (2016) Pauline M. Camacho et al. Endocrine Practice
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis
- (2016) Paul D. Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cancel the denosumab holiday
- (2016) M. R. McClung OSTEOPOROSIS INTERNATIONAL
- A systematic review of intervention thresholds based on FRAX
- (2016) John A. Kanis et al. Archives of Osteoporosis
- Intervention Thresholds and the Diagnosis of Osteoporosis
- (2015) John A Kanis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A BMD threshold for treatment efficacy in osteoporosis? A need to consider the whole evidence base
- (2015) E. McCloskey OSTEOPOROSIS INTERNATIONAL
- Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX
- (2015) N. C. Harvey et al. OSTEOPOROSIS INTERNATIONAL
- Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years
- (2015) S. Ferrari et al. OSTEOPOROSIS INTERNATIONAL
- Challenges for the Development of Bone-Forming Agents in Europe
- (2014) John A. Kanis et al. CALCIFIED TISSUE INTERNATIONAL
- The Effect of Latitude on the Risk and Seasonal Variation in Hip Fracture in Sweden
- (2014) Anders Odén et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Clinician’s Guide to Prevention and Treatment of Osteoporosis
- (2014) F. Cosman et al. OSTEOPOROSIS INTERNATIONAL
- Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX
- (2012) Eugene V McCloskey et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: The fracture intervention trial
- (2012) Meghan G Donaldson et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A comparison of case-finding strategies in the UK for the management of hip fractures
- (2012) H. Johansson et al. OSTEOPOROSIS INTERNATIONAL
- A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
- (2012) S. Lekamwasam et al. OSTEOPOROSIS INTERNATIONAL
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- A systematic review of hip fracture incidence and probability of fracture worldwide
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- FRAX® with and without Bone Mineral Density
- (2011) John A. Kanis et al. CALCIFIED TISSUE INTERNATIONAL
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Erratum to: A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- High fracture probability with FRAX® usually indicates densitometric osteoporosis: implications for clinical practice
- (2011) W. D. Leslie et al. OSTEOPOROSIS INTERNATIONAL
- The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005–2008
- (2011) B. Dawson-Hughes et al. OSTEOPOROSIS INTERNATIONAL
- A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX®
- (2010) John A. Kanis et al. BONE
- Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial
- (2010) Ann V Schwartz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®
- (2009) John A. Kanis et al. BONE
- Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
- (2009) J. Compston et al. MATURITAS
- Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study
- (2008) E. V. McCloskey et al. OSTEOPOROSIS INTERNATIONAL
- Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks
- (2008) N. D. Nguyen et al. OSTEOPOROSIS INTERNATIONAL
- FRAX™ and the assessment of fracture probability in men and women from the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started